clinical trial · NCT06332014
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
Amgen·phase4·active not recruiting·n = 102
OsteoporosisProlia
brief summary
The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.
started
Aug 6, 2024
primary completion
Jan 23, 2027
completion
Jan 23, 2027
last updated
Feb 12, 2026
official title
A Phase 4 Single Arm Open Label Study for the Efficacy and Safety of Prolia in Treatment of Male Subjects With Osteoporosis in Mainland China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol